The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide BPC 157: What you need to know before you try it You are hearing more about BPC 157. Patients ask about it daily. Here are the most common questions answered. What is BPC 157? BPC 157 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger? Everyone online is suddenly injecting peptides. But almost nobody understands the scienceor the regulation. The FDA recently shifted several peptides off the Category 2 safety risk list tied to compounding rules. First, that